on Zomedica Corp. (NASDAQ:ZOM)
Zomedica Enhances TRUVIEW® Microscopy with AI Diagnostic Tool
Zomedica Corp. has integrated advanced AI capabilities into its TRUVIEW® AI digital microscopy platform, enhancing hematology and cytology diagnostics for veterinary clinics. The company aims to improve diagnostic speed and consistency by automating blood film interpretations, with plans to expand to skin and ear cytology.
The AI update is accessible through a software upgrade for existing TRUVIEW users, eliminating additional hardware costs. This enhancement turns the TRUVIEW microscope into a comprehensive diagnostic tool, potentially increasing adoption by high-volume veterinary practices.
William Cambell, Zomedica's VP of Imaging, highlighted the AI-enabled platform's capacity to deliver faster and consistent diagnostic results, thus strengthening its competitive position. The AI system records complex cellular patterns, identifying conditions like anemia and infections.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Zomedica Corp. news